Literature DB >> 17406980

Fas antigen and sporadic Alzheimer's disease in Southern Italy: evaluation of two polymorphisms in the TNFRSF6 gene.

Virginia Andreoli1, Giuseppe Nicoletti, Nelide Romeo, Francesca Condino, Antonella La Russa, Maria Liguori, Ida Manna, Patrizia Spadafora, Aldo Quattrone, Rita Cittadella.   

Abstract

Tumor Necrosis Factor Receptor Super Family 6 gene (TNFRSF6), also known as FAS, encodes the Fas antigen, a cell surface receptor mediating cell apoptosis, situated on chromosome 10q located near the region of linkage to sporadic Alzheimer's disease (sAD). FAS levels have been reported elevated in the brain of AD patients. Due to both positional and pathobiological criteria, the association of the FAS antigen with this pathology is of great interest. We have tested two SNPs in the FAS gene in 223 Italian patients with non-familial AD from Southern Italy (Calabria region) and 211 healthy control subjects. No significant differences in allelic and genotypic distributions were found between cases and controls, or late and early-onset AD patients, thus suggesting that these polymorphisms do not represent an AD risk factor in our population.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17406980     DOI: 10.1007/s11064-007-9329-6

Source DB:  PubMed          Journal:  Neurochem Res        ISSN: 0364-3190            Impact factor:   3.996


  24 in total

1.  Linkage studies in familial Alzheimer disease: evidence for chromosome 19 linkage.

Authors:  M A Pericak-Vance; J L Bebout; P C Gaskell; L H Yamaoka; W Y Hung; M J Alberts; A P Walker; R J Bartlett; C A Haynes; K A Welsh
Journal:  Am J Hum Genet       Date:  1991-06       Impact factor: 11.025

2.  Fas promoter -670 polymorphism is associated with development of anti-RNP antibodies in systemic lupus erythematosus.

Authors:  Y H Lee; Y R Kim; J D Ji; J Sohn; G G Song
Journal:  J Rheumatol       Date:  2001-09       Impact factor: 4.666

3.  Segregation of a missense mutation in the amyloid precursor protein gene with familial Alzheimer's disease.

Authors:  A Goate; M C Chartier-Harlin; M Mullan; J Brown; F Crawford; L Fidani; L Giuffra; A Haynes; N Irving; L James
Journal:  Nature       Date:  1991-02-21       Impact factor: 49.962

4.  Evidence for genetic linkage of Alzheimer's disease to chromosome 10q.

Authors:  L Bertram; D Blacker; K Mullin; D Keeney; J Jones; S Basu; S Yhu; M G McInnis; R C Go; K Vekrellis; D J Selkoe; A J Saunders; R E Tanzi
Journal:  Science       Date:  2000-12-22       Impact factor: 47.728

5.  Susceptibility locus for Alzheimer's disease on chromosome 10.

Authors:  A Myers; P Holmans; H Marshall; J Kwon; D Meyer; D Ramic; S Shears; J Booth; F W DeVrieze; R Crook; M Hamshere; R Abraham; N Tunstall; F Rice; S Carty; S Lillystone; P Kehoe; V Rudrasingham; L Jones; S Lovestone; J Perez-Tur; J Williams; M J Owen; J Hardy; A M Goate
Journal:  Science       Date:  2000-12-22       Impact factor: 47.728

6.  Identification and characterization of polymorphisms in the promoter region of the human Apo-1/Fas (CD95) gene.

Authors:  Q R Huang; D Morris; N Manolios
Journal:  Mol Immunol       Date:  1997-06       Impact factor: 4.407

7.  Evaluation of a new Apo-1/Fas promoter polymorphism in rheumatoid arthritis and systemic lupus erythematosus patients.

Authors:  Q R Huang; V Danis; M Lassere; J Edmonds; N Manolios
Journal:  Rheumatology (Oxford)       Date:  1999-07       Impact factor: 7.580

8.  Apolipoprotein E: high-avidity binding to beta-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease.

Authors:  W J Strittmatter; A M Saunders; D Schmechel; M Pericak-Vance; J Enghild; G S Salvesen; A D Roses
Journal:  Proc Natl Acad Sci U S A       Date:  1993-03-01       Impact factor: 11.205

Review 9.  Genetic susceptibility to Alzheimer disease.

Authors:  M A Pericak-Vance; J L Haines
Journal:  Trends Genet       Date:  1995-12       Impact factor: 11.639

10.  Cloning of a gene bearing missense mutations in early-onset familial Alzheimer's disease.

Authors:  R Sherrington; E I Rogaev; Y Liang; E A Rogaeva; G Levesque; M Ikeda; H Chi; C Lin; G Li; K Holman; T Tsuda; L Mar; J F Foncin; A C Bruni; M P Montesi; S Sorbi; I Rainero; L Pinessi; L Nee; I Chumakov; D Pollen; A Brookes; P Sanseau; R J Polinsky; W Wasco; H A Da Silva; J L Haines; M A Perkicak-Vance; R E Tanzi; A D Roses; P E Fraser; J M Rommens; P H St George-Hyslop
Journal:  Nature       Date:  1995-06-29       Impact factor: 49.962

View more
  3 in total

1.  Parent-of-origin effects of FAS and PDLIM1 in attention-deficit/hyperactivity disorder.

Authors:  Ke-Sheng Wang; Xuefeng Liu; Qunyuan Zhang; Nagesh Aragam; Yue Pan
Journal:  J Psychiatry Neurosci       Date:  2012-01       Impact factor: 6.186

2.  Differences in abundances of cell-signalling proteins in blood reveal novel biomarkers for early detection of clinical Alzheimer's disease.

Authors:  Mateus Rocha de Paula; Martín Gómez Ravetti; Regina Berretta; Pablo Moscato
Journal:  PLoS One       Date:  2011-03-24       Impact factor: 3.240

3.  The FAS -670A>G polymorphism influences susceptibility to systemic sclerosis phenotypes.

Authors:  J Broen; P Gourh; B Rueda; M Coenen; M Mayes; J Martin; F C Arnett; T R D J Radstake
Journal:  Arthritis Rheum       Date:  2009-12
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.